IP Library Granted Patent US 11,406,485
Granted Patent B2
US 11,406,485 · App. 14/649,838 · Granted Aug 9, 2022

In vivo positionable filtration devices and methods related thereto

Inventors: Steven W. Hetts (Hillsborough, CA); Anand S. Patel (San Francisco, CA); Mark W. Wilson (San Francisco, CA)
Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
A61F2/013A61M1/3615A61F2/011A61F2/0105A61F2/0108A61F2002/015A61F2230/0067A61M1/3679A61M25/0029A61M2025/1052A61M2025/1097
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,406,485
App. No.
14/649,838
Granted
Aug 9, 2022
Kind
B2
Abstract

In vivo positionable filtration devices are provided that filter one or more therapeutic agents in blood flowing in a blood vessel. The filtration devices include an elongated member and a filtering component coupled to the elongated member. The elongated member and the filtering component are dimensioned for positioning within the blood vessel of a human or non-human animal. Further, the filtering component includes a filtration material to filter the one or more therapeutic agents from the blood. Methods of in vivo filtration of the one or more therapeutic agents are also provided. The methods include positioning a filtration device in the blood vessel of a body of the human or non-human animal, and administering a therapeutic agent upstream from a target tissue site to direct flow of the therapeutic agent to the target tissue site and then to the filtration device. The filtration device is positioned downstream from the target tissue site.

Claims (32)

1. An in vivo filtration device positionable in a vein of a human or a non-human animal, the filtration device comprising:

a catheter having a lumen;

an elongated control member positioned within the lumen of the catheter,

a filtration material disposed along an axis of the elongated control member within the lumen of the catheter, wherein the filtration material comprises resin beads within one or more porous membranes configured to adsorb or bind a chemotherapeutic agent administered in an artery supplying blood to an organ comprising a tumor,

wherein the filtration device is dimensioned for positioning within the vein draining the blood from the organ in the human or non-human animal.

2. The filtration device of claim 1 , wherein the resin adsorbs the chemotherapeutic agent.

3. The filtration device of claim 1 , wherein the resin chemically binds the chemotherapeutic agent.

4. The filtration device of claim 1 , wherein the resin is an ion exchange resin.

5. The filtration device of claim 1 , wherein the resin is a strong acid cation polymer resin.

6. The filtration device of claim 1 , wherein the resin comprises a polymeric adsorbent resin without ion exchange.

7. The filtration device of claim 1 , wherein the resin includes sulfonate groups that ionically bind to the chemotherapeutic agent.

8. The filtration device of claim 1 , wherein the resin is coated with heparin, polymethyl-methacrylate, or chitosan.

9. The filtration device of claim 1 , wherein the elongated member is displaceable out a distal end of the catheter.

10. The filtration device of claim 1 , wherein the filtration material is removable from the catheter while the catheter is positioned in the vein.

11. The filtration device of claim 1 , wherein the chemotherapeutic agent is doxorubicin.

12. The filtration device of claim 1 , wherein the catheter has a diameter of 8 mm-14 mm or 22 mm-30 mm.

13. The filtration device of claim 1 , wherein the one or more porous membranes comprise a porous membrane shaped to increase and then decrease in cross-sectional area from a distal end to a proximal end.

14. The filtration device of claim 1 , wherein the one or more porous membranes comprise a porous membrane that is expandable to occupy a cross sectional area of the vein within which the porous membrane is deployed.

15. The filtration device of claim 14 , wherein the porous membrane is biased to an expanded state so that when the porous membrane is displaced outside the catheter, the porous membrane is expanded to occupy the cross sectional area of the vein.

16. An in vivo positionable filtration device for filtering a chemotherapeutic agent in blood flowing in a blood vessel, the filtration device comprising:

an elongated control member comprising a distal end; and

a filtering component carried on the distal end of the elongated control member comprising:

a porous membrane comprising a proximal end and a distal end, the porous membrane shaped to increase and then decrease in cross-sectional area from the distal end of the porous membrane to the proximal end of the porous membrane, the porous membrane configured to be deployed within the blood vessel such that the blood flowing through the blood vessel passes through an interior of the filtering component; and

filtration material comprising a plurality of beads disposed within the porous membrane configured to bind the chemotherapeutic agent to the beads as the blood flows through the interior of the filtering component.

17. The device of claim 16 , wherein the beads comprise material configured to adsorb the chemotherapeutic agent.

18. The device of claim 16 , wherein the beads comprise ion exchange resin.

19. The device of claim 18 , wherein the resin is a strong acid cation exchange polymer resin.

20. An in vivo positionable filtration device for filtering a chemotherapeutic agent in blood flowing in a blood vessel, the filtration device comprising:

an elongated member comprising a distal end; and

a filtering component carried on the distal end of the elongated member comprising:

a porous membrane comprising a proximal end and a distal end, the porous membrane expandable when deployed within the blood vessel to occupy a cross sectional area of the blood vessel within which the porous membrane is deployed such that the blood flowing through the blood vessel passes through an interior of the filtering component; and

filtration material comprising a plurality of beads disposed within the porous membrane configured to bind or adsorb the chemotherapeutic agent to the beads as the blood flows through the interior of the filtering component.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2016
From: HETTS, STEVEN W.; PATEL, ANAND S.; WILSON, MARK W.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 038197/0918 →
CONFIRMATORY LICENSE Recorded Oct 2, 2015
From: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 036745/0617 →
Continuity (3)
Provisional Application 61784507 · Mar 14, 2013
Provisional Application 61745183 · Dec 21, 2012
Related Publication 20150305850A1 · Oct 29, 2015